Gene Therapy Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Gene Therapy stocks.

Gene Therapy Stocks Recent News

Date Stock Title
May 10 XENE Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q1 2024 Earnings Call Transcript
May 10 XENE Xenon Pharmaceuticals Inc (XENE) Reports Increased Losses in Q1 2024, Despite Advancements in ...
May 10 XENE Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus
May 10 XENE Xenon Pharmaceuticals Inc. (XENE) Q1 2024 Earnings Call Transcript
May 9 XENE Xenon Pharma GAAP EPS of -$0.62 beats by $0.05
May 9 XENE Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 9 LXEO Lexeo Therapeutics reports Q1 results
May 9 LXEO Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights
May 9 BEAM Beam Therapeutics Inc. (NASDAQ:BEAM) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
May 9 GNPX Genprex co-founder, CEO passes away
May 8 GNPX Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner
May 8 XENE Xenon Pharma Q1 2024 Earnings Preview
May 8 XENE Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024
May 8 BEAM Beam Therapeutics (BEAM) Q1 Loss Narrows, Revenues Miss
May 8 BEAM Beam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare Conference
May 8 BEAM Beam Therapeutics Inc (BEAM) Reports Q1 2024 Earnings: A Detailed Overview
May 7 TSHA Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14
May 7 XENE Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference
May 7 GNPX Sidoti Events, LLC's Virtual May Micro-Cap Conference
May 7 ABEO Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Gene Therapy

In the medicine field, gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. The first attempt at modifying human DNA was performed in 1980 by Martin Cline, but the first successful nuclear gene transfer in humans, approved by the National Institutes of Health, was performed in May 1989. The first therapeutic use of gene transfer as well as the first direct insertion of human DNA into the nuclear genome was performed by French Anderson in a trial starting in September 1990.
Between 1989 and February 2016, over 2,300 clinical trials were conducted, with more than half of them in phase I.
Not all medical procedures that introduce alterations to a patient's genetic makeup can be considered gene therapy. Bone marrow transplantation and organ transplants in general have been found to introduce foreign DNA into patients. Gene therapy is defined by the precision of the procedure and the intention of direct therapeutic effect.

Browse All Tags